[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"University Hospitals of North Midlands NHS Trust\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":189},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,39,63,82,104,125,148,168],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100593455","anatomical-landmarks-for-chest-wall-perforators-used-for-partial-breast-reconstruction-100593455",false,"NCT07006662","Anatomical Landmarks for Chest Wall Perforators Used for Partial Breast Reconstruction","Anatomical Landmarks for Chest Wall Perforators Used for Partial Breast Reconstruction (LaPBrecon)","(LaPBrecon)","Inclusion Criteria:\n\n* Patients undergoing elective breast surgery\n* Age ≥ 18 years\n* Female\n* BMI ≤ 30 kg\u002Fm2\n* Willing and able to give fully informed consent,\n* Willing and able to comply with the study procedures\n\nExclusion Criteria:\n\n* Pregnant patients\n* Previous bilateral Breast or axillary surgery\n* Undergoing bilateral oncoplastic procedure or requiring bilateral pre-operative marking\n* Undergoing breast surgery requiring pre-operative marking of some of the landmarks and has had contralateral breast or axillary surgery in the past\n* Surgery planned within 24 hours of screening for eligibility\n* Known history of allergy or contact dermatitis to ultrasound gels","FEMALE","18 Years",{"count":20,"type":21},20,"ESTIMATED","OBSERVATIONAL","The aim of this 6-month proof-of-concept study is to map out the chest wall perforators in relation to anatomical landmarks for partial breast reconstruction.",[25],"Breast Cancer Female","NOT_YET_RECRUITING","2026-06-08",{"date":29,"type":30},"2026-06-09","ACTUAL",{"date":32,"type":21},"2026-07-01",{"date":34,"type":21},"2027-12-01",{"name":36,"class":37},"University Hospitals of North Midlands NHS Trust","OTHER",1,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":4,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":50,"conditions":51,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":38},"100567802","newpromri-pathway---a-new-prostate-magnetic-resonance-imaging-mri-pathway-100567802","NCT06672926","NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway","NEWPROMRI","Inclusion Criteria:\n\n* MRI radiographers in University Hospitals of North Midlands (UHNM) and or University Hospitals of Derby and Burton (UHDB) with over 5 years' experience in MRI of the prostate.\n* Radiographers from UHNM or UHDB who have completed an online and hands on study specific training materials before the testing phase.\n* Retrospective data of 800 patients each from UHNM and UHDB who have had mpMRI and went on to have a biopsy.\n\nExclusion Criteria:\n\n* Non-MRI radiographers.\n* Radiographers who did not completed an online and hands on study specific training materials before the testing phase.\n* Non-mpMRI.",true,"ALL",{"count":49,"type":21},1600,"Prostate cancer is the second most common cancer in men worldwide. The demand for magnetic resonance imaging (MRI) to diagnose and manage prostate cancer is continually growing. There is, however, a severe global shortage of radiologists who review and make decisions on prostate scans. This shortage causes compromises that are inefficient and negatively affect care provision, patient outcomes, and patient experiences. Two key examples of these compromises are that every patient receives a gadolinium contrast injection during a prostate MRI scan and patients often require multiple imaging appointments. If radiologists' knowledge of making prostate MRI decisions around these compromises could be harnessed and passed to radiographers (who are trained to acquire the MRIs but currently do not review them) with a computerised system to support clinical decision-making, this would have enormous potential to improve the diagnosing and managing prostate cancer.",[52,53],"Prostate Cancer","MRI","RECRUITING","2026-03-25",{"date":57,"type":30},"2026-03-30",{"date":59,"type":30},"2025-09-23",{"date":61,"type":21},"2026-12",{"name":36,"class":37},{"id":64,"slug":65,"hasResults":11,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":46,"sex":47,"minAge":18,"maxAge":4,"enrollmentInfo":70,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":72,"conditions":73,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":76,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":81,"locationsCount":38},"100557905","can-imaging-be-an-alternative-to-exercise-testing-as-a-predictor-of-surgical-fitness-100557905","NCT06544187","Can Imaging be an Alternative to Exercise Testing as a Predictor of Surgical Fitness?","RESPIRE","Inclusion Criteria:\n\nInclusion criteria for patients (cohort 1)\n\n* Patients diagnosed oesophageal\u002Fgastric or pancreatic cancer.\n* Patients who have or a under consideration for a CPET investigation.\n* Aged ≥ 18.\n* Existing UHNM Patient.\n* Willing and able to give fully informed consent.\n* Willing and able to comply with the study procedures.\n\nInclusion criteria for staff volunteers (cohort 2)\n\n* Aged ≥ 18 years.\n* Willing and able to give fully informed consent.\n* Willing and able to comply with the study procedures.\n* UHNM member of staff.\n\nExclusion Criteria:\n\nExclusion criteria for patients (cohort 1)\n\n* Patients with contraindications to MRI due to safety at 3T.\n* Patients with metalwork within the imaging field of view (e.g., knee replacement).\n* Claustrophobic patients.\n* Patients outside of stated age range to ensure informed consent.\n* Patients not referred for CPET investigations.\n* Patients that are pregnant.\n* Patients that are unable to communicate in English.\n* Patients lacking the capacity and capability to give fully informed consent.\n* Patients participating in any other interventional studies with a contraindication to their participation.\n* Patients for whom the addition of an MRS scan would delay any part of their standard treatment pathway.\n* History of diabetes.\n\nExclusion criteria for staff volunteers (cohort 2)\n\n* Volunteers with contraindications to MRI due to safety at 3T.\n* Volunteers with metalwork within the imaging field of view (e.g., knee replacement).\n* Claustrophobic volunteers.\n* Volunteers outside of stated age range to ensure informed consent.\n* Volunteers that are pregnant.\n* Volunteers that are unable to communicate in English.\n* Volunteers lacking the capacity and capability to give fully informed consent.\n* Volunteers participating in any other interventional studies with a contraindication to their participation.\n* Known or suspected medical conditions pertinent to the area being scanned.\n* History of diabetes.",{"count":71,"type":21},56,"This study aims to explore an alternative method for assessing a participant's readiness for surgery, specifically for those undergoing surgery for gastric, oesophageal, or pancreatic cancer. Surgery for these diseases is extremely demanding on the body and surgeons need to be confident that a patient can tolerate the procedure.\n\nTraditionally, participants undergo Cardiopulmonary Exercise Tests (CPET) to determine their fitness for surgery. This involves cycling on an exercise bike with increasing resistance until the resistance is too great to continue cycling at a constant rate. An individual's maximum rate of oxygen consumption (VO2max) and the anaerobic threshold (AT) are calculated during CPET and used by surgeons as a predictor for surgical fitness. CPET tests can be physically demanding for participants and are very resource intensive. Furthermore, some patients may not be able to tolerate exercise tests due to physical constraints.\n\nAn alternative method, Magnetic Resonance Spectroscopy (MRS), could be used to measure an individual's fitness prior to surgery. Within this study, MRS will be used to determine the levels of fat within the thigh muscle, which in turn may be able to be used to predict fitness for surgery.\n\nThe first phase includes recruiting participants on the surgical pathway. MRS will be performed as an additional examination, typically on the same day as the CPET. Fat levels determined from MRS will be compared with conventional CPET outcomes (VO2max and AT). This analysis aims to determine if MRS derived fat levels correlates with VO2max and AT and, if correlation is high, potentially providing an alternative to CPET for patients who cannot tolerate exercise tests.\n\nThe second phase involves recruiting volunteers who will undergo repeated MRS scans to assess the reliability of MRS methods. This process allows us to understand the consistency of MRS derived fat levels over both short and long-term intervals.\n\nThe potential benefits of this project include an additional pathway for assessing fitness for surgery or enhancing the presurgical pathway for patients by providing an alternative method for fitness assessment. This study aims to provide evidence that could present an alternative method of assessing a patient's fitness for surgery. The goal is to explore an alternative that may complement or refine current practices in preoperative assessments.",[74,75],"Surgical Fitness","Imaging",{"date":77,"type":30},"2026-03-27",{"date":79,"type":30},"2025-01-06",{"date":61,"type":21},{"name":36,"class":37},{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":4,"eligibilityCriteria":88,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":89,"targetDuration":4,"studyType":90,"phases":91,"briefSummary":93,"conditions":94,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":38},"100570719","early-phase-1-vitamin-c-and-hiprex-in-ruti-100570719","NCT06710899","Vitamin C and Hiprex in rUTI","Does Vitamin C Improve the Efficacy of Methenamine Hippurate (Hiprex®) in Prophylaxis of Recurrent Urinary Tract Infections? A Proof of Concept Study","Inclusion Criteria:\n\n* Female\n* Age ≥18 years\n* Recurrent proven UTI, defined as \"two or more proven infections in six months or three or more infections in six months\"\n* Willing and able to give fully informed consent\n* Patients suitable for prophylaxis following discussion with their clinician.\n* No contra-indications to treatment with methenamine hippurate or Vitamin C\n* All women will have undergone standard diagnostic work-up and have followed routine conservative UTI prevention measures.\n* A working email address to be used to submit urine pH results\n* Willing and able to comply with the study procedures\n* Females of childbearing potential must be willing to use a highly effective method of contraception (hormonal or barrier method of birth control; abstinence; sterilisation or vasectomised partner)\n\nExclusion Criteria:\n\n* Males\n* Women who are pregnant or breast-feeding\n* Contraindications to methenamine hippurate as described in BNF: known allergy, gout, severe metabolic acidosis, severe dehydration, eGFR less than 10 ml\u002Fmin, severe hepatic impairment\n* Currently using vitamin C containing supplement or cranberry extract tablets\n* Women using urinary alkalinisation agents, e.g potassium citrate, sodium bicarbonate\n* Currently receiving any form of bladder instillation or intradetrusor Onabotulinum Toxin A injections\n* Patients already on low-dose antibiotics or methenamine hippurate (due to delay that will be incurred by 3-month washout period)\n* Indwelling urinary catheter in situ or performing clean intermittent self-catheterisation\n* Correctable urinary tract abnormalities, e.g., urinary tract calculi, urinary retention\n* Formation of ileal conduit or augmented bladder\n* Neurogenic bladder dysfunction\n* Hyperoxaluria",{"count":20,"type":21},"INTERVENTIONAL",[92],"EARLY_PHASE1","A single centre proof of concept study to assess whether Vitamin C improves the efficacy of Methenamine Hippurate (Hiprex®) in the prophylaxis of recurrent urinary tract infections (rUTIs) in women",[95],"Urinary Tract Infections","2026-02-10",{"date":98,"type":30},"2026-02-11",{"date":100,"type":21},"2027-01",{"date":102,"type":21},"2028-01",{"name":36,"class":37},{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":110,"eligibilityCriteria":111,"healthyVolunteers":11,"sex":47,"minAge":18,"maxAge":4,"enrollmentInfo":112,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":114,"conditions":115,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":124,"locationsCount":38},"100611749","anaesthetic-technique-for-minor-lower-limb-amputation-surgery-atllas-100611749","NCT07244627","Anaesthetic Technique for Minor Lower Limb Amputation Surgery (ATLLAS)","Anaesthetic Technique for Minor Lower Limb Amputation Surgery (ATLLAS): A Retrospective Review of Outcomes","ATLLAS","Inclusion Criteria:\n\n* Adult patients (aged 18 and over).\n* National Vascular Registry data field - Procedure undertaken - amputation through ankle or below.\n* Procedure undertaken between 1st January 2019 and 1st January 2025.\n\nExclusion Criteria:\n\n* Amputations due to trauma, neurological disease or chronic pain",{"count":113,"type":21},300,"Major lower limb amputation is recognised as a significant cause of morbidity and mortality. In the United Kingdom, 30-day in-hospital mortality is up to 8.7%. Minor lower limb amputations, defined as amputation at or below the ankle, are often considered minor procedures, but mortality at one month is 3.5%, similar to that of below knee amputations and 20% at one year. Any amputation is an indicator of poor health and should be considered a pivotal event in a patient's healthcare journey. In England alone, 21,738 minor lower limb amputations were performed between 2017 and 2020, with annual procedures on an increasing trajectory. Recent work has demonstrated striking regional differences in rates of major lower limb amputations in England which the authors ascribed to inequalities in the provision of healthcare. Improving the regional provision of support services for amputees is also part of the current governments NHS Long Term Workforce Plan (https:\u002F\u002Flordslibrary.parliament.uk\u002Faccess-to-prosthetics-for-amputees-in-england\u002F).\n\nWhile multiple studies have aimed to assess the impact of anaesthetic technique on outcomes following major lower limb amputation, there is little published data on factors impacting morbidity and mortality following minor lower limb amputation surgery. Evidence from the USA has shown deleterious effect of general anaesthesia (GA) as compared to regional anaesthesia for minor lower limb amputation in patients with peripheral artery disease. Higher rates of post-operative wound disruption, pneumonia, prolonged intubation, and septic shock were demonstrated with general anaesthesia rather than regional anaesthesia.\n\nInvestigators have performed a single centre retrospective review of 382 patients undergoing minor lower limb amputation for vascular disease in our Trust (UHNM). We found that our patients undergoing these procedures under peripheral nerve block (PNB) techniques were older with higher rates of heart and kidney disease than those receiving a general anaesthetic. Despite this, these patients had reduced complications and length of hospital stay than the fitter patients. The difference seen here became even more pronounced following propensity matching. Investigators demonstrated a clinically significant reduction in the respiratory complication rate of 5.3% and overall complication rate of 12% and a reduction in length of stay of 6 days following use of peripheral nerve blocks rather than general anaesthesia. Investigators also demonstrated a reduction in length of stay of 4 days when DARF Form v4 - July 2023 16 administering peripheral nerve blocks rather than neuraxial anaesthesia (NA). This small and monocentric study suggests that there is value in repeating this process in a larger, national dataset.",[116,117],"Anesthesia","Amputation; Traumatic, Leg, Lower","2025-12-03",{"date":120,"type":30},"2025-12-04",{"date":122,"type":21},"2026-01",{"date":100,"type":21},{"name":36,"class":37},{"id":126,"slug":127,"hasResults":11,"nctId":128,"briefTitle":129,"officialTitle":130,"acronym":131,"eligibilityCriteria":132,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":133,"enrollmentInfo":134,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":136,"conditions":137,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":140,"lastUpdatePostDateStruct":141,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":38},"100581587","ureteric-identification-using-indocyanine-green-dye-versus-conventional-ureteric-stenting-to-reduce-post-operative-pain-and-surgical-morbidity-during-endometriosis-surgery-100581587","NCT06852248","Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting to Reduce Post-operative Pain and Surgical Morbidity During Endometriosis Surgery","Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting to Reduce Post-operative Pain and Surgical Morbidity During Endometriosis Surgery: A Pilot Trial (ICE Trial)","ICE","Inclusion Criteria:\n\n* Women aged 18 to 50 years\n* Scheduled for laparoscopic or robotic-assisted surgical excision of deep endometriosis (DE) where ureteric stenting is planned.\n* Willing and able to provide consent for participation in the study\n\nExclusion Criteria:\n\n* Confirmed or suspected pregnancy at the time of enrolment.\n* Suspicion or confirmation of malignancy.\n* History of ureteric injury from prior surgery or trauma\n* Medically unfit for surgery due to the following conditions:\n\n  * Uncontrolled diabetes mellitus.\n  * Severe Chronic Obstructive Pulmonary Disease (COPD).\n  * Hypertrophic cardiomyopathy or significant cardiac conditions (e.g., recent myocardial infarction, aortic stenosis).\n  * History of stroke or severe kyphoscoliosis.\n  * Uncontrolled hypertension.\n* Body mass index (BMI): BMI greater than 45","50 Years",{"count":135,"type":21},70,"Endometriosis is a common (around 1 in 10 women), non-cancerous condition where tissue similar to the womb lining is found growing elsewhere, most commonly inside the pelvis. Symptoms vary but can include intense pelvic pain and infertility.\n\nEndometriosis that is very deep and painful may need surgery, which risks damage to the tubes that drain urine from the kidneys to the bladder (ureters). To reduce this risk, surgeons may put tiny plastic tubes called \"stents\" inside the ureters. These stents can stay for up-to 4 weeks following surgery but can cause severe pain and blood in the urine. Squirting a dye into the ureters, rather than using stents, may cause less pain for women after surgery whilst not making the removal of endometriosis worse, the operation take longer, or increasing the rates of complications (such as bleeding or damage to internal organs). Before a full clinical study can be run, the investigators need to understand whether this is possible, by doing a feasibility study",[138,139],"Endometriosis","Deep Endometriosis","2025-08-26",{"date":142,"type":30},"2025-09-03",{"date":144,"type":30},"2025-07-29",{"date":146,"type":21},"2028-03",{"name":36,"class":37},{"id":149,"slug":150,"hasResults":11,"nctId":151,"briefTitle":152,"officialTitle":153,"acronym":4,"eligibilityCriteria":154,"healthyVolunteers":11,"sex":47,"minAge":18,"maxAge":4,"enrollmentInfo":155,"targetDuration":4,"studyType":90,"phases":156,"briefSummary":158,"conditions":159,"keywords":161,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":140,"lastUpdatePostDateStruct":163,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":167,"locationsCount":38},"100529557","trans-radial-superior-rectal-artery-embolisation-for-haemorrhoids-100529557","NCT06175325","Trans-radial Superior Rectal Artery Embolisation for Haemorrhoids","Pilot Study of the Safety and Efficacy of Trans-radial Superior Rectal Artery Embolisation for the Treatment of Haemorrhoids","Inclusion Criteria:\n\nPatients eligible for the study must comply with all of the following prior to enrolment:\n\n* Patients with grade II-IV haemorrhoid disease with re-current or active bleeding\n* Patients with (i) who do not wish to undergo surgery for their symptoms\n* Patients with (i) despite recent surgery\n* Patients willing and able to give fully informed consent\n* Patients aged ≥18 years\n\nExclusion Criteria:\n\n* Patients who are not otherwise fit for surgery\n* Patients with significant ano-rectal comorbidities (cancer, fistula, abscesses)\n* Patient who are unable to sign the informed consent form.\n* Patients who are pregnant (completed as part of standard IRMER protocol)\n* Patients with history of significant colorectal disease or previous colectomy.\n* Patients with history of an allergic reaction to x-ray contrast\n* Patients who are currently involved in research",{"count":20,"type":21},[157],"NA","Endovascular embolisation is already a common procedure for bleeding haemorrhoids in the acute setting, where surgical options are not possible or have been exhausted. This pilot study aims to add to the small body of evidence that transarterial embolisation of symptomatic haemorrhoids is also safe and effective in the elective setting, providing a good alternative to conventional surgical management. This is a day case procedure that is performed under local anaesthetic. For selected patients, this presents a less invasive management option with reduced potential morbidity. For a health care system under significant financial stress, this provides a potential means of cost improvement, the extent of which this study will try and quantify. A series of 20 selected patients will be recruited to undergo this procedure and then followed up for 24 months. The long-term goal of this pilot study is to form the basis of a national registry of such procedures.",[160],"Hemorrhoids",[162],"Embolisation",{"date":142,"type":30},{"date":165,"type":30},"2025-07-17",{"date":61,"type":21},{"name":36,"class":37},{"id":169,"slug":170,"hasResults":11,"nctId":171,"briefTitle":172,"officialTitle":172,"acronym":173,"eligibilityCriteria":174,"healthyVolunteers":11,"sex":47,"minAge":18,"maxAge":4,"enrollmentInfo":175,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":177,"conditions":178,"keywords":180,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":140,"lastUpdatePostDateStruct":183,"startDateStruct":184,"completionDateStruct":186,"leadSponsor":188,"locationsCount":38},"100516245","suprascapular-cuff-study-assessing-the-effects-of-size-and-type-of-rotator-cuff-tear-on-suprascapular-nerve-function-100516245","NCT06002009","SupraScapular Cuff Study: Assessing the Effects of Size and Type of Rotator Cuff Tear on Suprascapular Nerve Function","SSCuFF","Inclusion Criteria:\n\n• All patients age ≥18 years presenting to a UHNM shoulder clinic with a confirmed diagnosis of a rotator cuff tear (affecting one or both shoulders).\n\nExclusion Criteria:\n\n* Bony pathology (such as significant shoulder arthritis that would exclude isolated rotator cuff repair)\n* Grossly abnormal shoulder anatomy\n* Motor Neurone Disease\n* Cervical cord disease affecting the SSN nerve roots\n* Patients unable to undergo MRI scan\n* Previous surgery at the affected glenohumeral joint\n* Patients unable to tolerate NCS\n* Acute fracture affecting the glenohumeral joint\n* Recent glenohumeral joint dislocation (past 12 months)\n* Patients unable or unwilling to give full informed consent\n* Patients unable or unwilling to comply with the study procedures",{"count":176,"type":21},250,"The primary objective of the study is to determine in adult patients with a rotator cuff tear, what size and pattern of rotator cuff tear would result in damage to the suprascapular nerve.\n\nThe secondary objectives are\n\n1. To determine if an injured suprascapular nerve can recover if the rotator cuff tear is surgically repaired.\n2. To determine if there is a limit of retraction before the suprascapular nerve is irreversibly damaged.\n3. To determine factors that are protective against SSN injury.\n4. Can the patient data gathered be used to optimise operative procedures.",[179],"Orthopedic Disorder",[181,182],"Rotator cuff tear","Suprascapular nerve function",{"date":142,"type":30},{"date":185,"type":30},"2025-06-23",{"date":187,"type":21},"2029-09-30",{"name":36,"class":37},""]